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Effects of indomethacin on glomerular hemodynamics in experimental
diabetes. The glomerular hemodynamics were studied in streptozotocin
diabetic rats 3 months after the induction and in age-matched normal
animals. Indomethacin infusion failed to cause changes in glomerular
hemodynamics in normal rats but produced striking effects in the
diabetic rats: The afferent arteriolar hydraulic resistance increased
substantially while the efferent resistance rose moderately causing large
reductions in single nephron blood flow and in the hydraulic pressure in
the glomerular capillaries, Consequently, single nephron glomerular
filtration rate (SNGFR) was reduced significantly below normal. The
ultrafiltration coefficient of the glomerular membrane was significantly
lower in the diabetic than in the normal animals (2.8 versus 5.0 nI min
mm Hg) and remained unchanged during indomethacin infusion. Our
results suggest that the prostaglandin system compensates for the
changes in the glomerular hemodynamics induced by diabetes by
reducing the arteriolar resistances to increase the glomerular capillary
pressure making it possible to maintain normal values of SNGFR and
nephron blood flow.
The streptozotocin diabetic rat is a useful experimental model
for studies of renal function in early human insulin-dependent
diabetes mellitus [1, 2]. Thickening of the glomerular basement
membrane that is an integral part of chronic diabetic
glomerulopathy has been demonstrated in the streptozotocin
diabetic rat kidney [3], so this model can also be used to study
moderately advanced human diabetic glomerulopathy.
The influence of diabetes on the renal function has been
examined in the streptozotocin diabetic rat with micropuncture
methods: Three months alter the induction of diabetes glomer-
ular filtration rate (GFR) remains unchanged, but there is a
significant reduction in the ultrafiltration coefficient of the
glomerular membrane (Kf) associated with a substantial in-
crease in the hydraulic pressure in the glomerular capillaries.
The decrease in Kf may reflect diabetic glomerular lesions [3]
which, in turn, might be caused either by the generalized
diabetic angiopathy or conceivably result from chronically
increased GFR [41. The observed increase in the hydraulic
pressure in the glomerular capillaries could result from a
compensatory mechanism that acts to maintain GFR despite the
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decreased Kf. The renin prostaglandin systems are known to be
involved in maintaining kidney function in chronic renal failure
[5—8]. Therefore, the present study was made to test the hypo-
thesis that increased endogeneous synthesis of prostaglandin
acts to maintain renal function in long-term streptozotocin
diabetic rats. The microvascular determinants of GFR were
measured before and after inhibiting endogeneous prosta-
glandin synthesis with indomethacin in streptozotocin diabetic
rats 3 months after the induction of the diabetes and in
age-matched control rats.
Methods
Experiments were made on male Munich Wistar rats (Strain
WU, Ivanovas, Kisslegg im Algau, Federal Republic of Ger-
many). Diabetes was induced with streptozotocin (70 mg/kg) in
citric acid buffer into a tail vein. After a 48-hr delay the rats
were treated with 0.4 U/day of very long acting bovine insulin
(Ultralente MC, NOVO, Denmark) as described previously [2].
The control rats received sham injections of vehicle instead of
streptozotocin and insulin. All rats had free access to water and
a standard rat pellet diet (Rostock rat pellets, 0.5% W/W NaCI,
Korn og Foderstofkompagniet, Arhus, Denmark). Body weight
and urinary concentrations of glucose (Testape, Lilly, Indianap-
olis, Indiana, USA) and ketone bodies (Ketostix, Ames,
Elkhart, Indiana, USA) were recorded daily. Blood glucose
concentration (Reflomat, Boehringer-Mannheim, Federal Re-
public of Germany) was measured at noon once a week. The
week before the experiments began the mean values were 349
7 and 83 2 mgldl in diabetic and normal rats, respectively.
The rats were anesthetized with mactin (110 mg/kg body wt,
i.p.). Preparation of the animals and surgical procedures were
as described previously [2, 9]. Briefly, the trachea, urinary
bladder, left ureter, and femoral artery and vein were can-
nulated; the left kidney was immobilized in a plastic cup
superfused by prewarmed mineral oil.
To replace fluid losses during surgery, each rat was infused
with rat plasma (obtained by exsanguination of donor rats) at
the rate of 10 mllkg/hr for the first 45 mm, followed by a
sustaining infusion at 1.5 ml/kg/hr for the remainder of the
experiment [10]. Each rat was also given an infusion at 1.2 mllhr
of isotonic saline; 1 hr before micropuncture inulin-'4C-
carboxylic acid (CFA 399, Radiochemical Center Amersham,
United Kingdom) was added to this solution to deliver 50
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MCi/hr. After preparation of the kidney and 1 hr before micro-
puncture, each rat was given 60 jsCi/kg body wt of '311-human
serum albumin (1K 21S, Kjeller Inc., Oslo, Norway) and 2000
U/kg body wt of heparin administered intravenously in 0.2 to
0.5 ml isotonic saline. To maintain the arterial hematocrit
constant during the experiments, it was necessary to give the
diabetic rats an additional infusion of 1.0 mllhr of isotonic
saline. To exclude the possibility that this higher rate of saline
infusion caused the difference in renal function between the two
groups, separate experiments were carried out in four normal
rats. After an initial clearance period, 2 ml of isotonic saline
were administered as a bolus injection followed by a sustaining
infusion of 3.2 nillhr. Micropuncture experiments were made
during the initial period and repeated 15 mm after the bolus
injection.
Indomethacin was given to six diabetic and four age-matched
control rats. After a 48-mm control period (range, 35 to 61 mm)
in the diabetic group and 43 mm (range, 35 to 52 mm) in the
control group, prostaglandin biosynthesis was suppressed by
giving 3.5 mg/kg of indomethacin (Merck, Sharp & Dohme,
Haarlem, The Netherlands) dissolved with equimolar amounts
of Na2CO3 (100 mM) [11]; about 0.04 ml of this solution was
given as a bolus injection followed by a sustaining infusion of
indomethacin (3.5 mg/kg/hr).
The micropuncture measurements were carried out in ran-
dom order in the initial control period and repeated 15 mm after
the bolus injection of indomethacin.
Separate time control experiments were made in three dia-
betic rats to exclude the possibility that the changes in nephron
function observed during the indomethacin infusion period
were a result of changes occurring with time during micropunc-
ture. Micropuncture measurements were made during an initial
control period of 41 mm (range, 38 to 45 mm) and repeated 15
mm later during a second control period.
To measure single nephron GFR (SNGFR) timed quantitative
collections of tubular fluid were obtained from the distal ex-
treme of the proximal convoluted tubule at the pre-existing
free-flow pressure [2, 9]. To determine the single nephron
filtration fraction blood samples were collected from surface
efferent arterioles (welling points) as described previously [12].
Systemic arterial blood samples were obtained from a catheter
in the femoral artery. Time averaged hydraulic pressures were
recorded in the glomerular capillaries (PG), Bowman spaces
(PB), efferent arterioles (PE), proximal and distal tubules (PT and
PD), respectively, using a servo-nulling micropuncture trans-
ducer system (Model 4 A, Instrumentation for Physiology and
Medicine, San Diego, California, USA) as described previously
[2, 12]. To measure GFR timed collections of urine from the left
ureter were made under mineral oil in preweighed vials.
At the end of the experiments the kidney weight was deter-
mined after allowing the intrarenal blood to drain.
The tubular fluid and the blood samples from the efferent
arterioles were treated as described previously [9, 12]. Systemic
plasma protein concentration, CA, was measured by the Lowry
method with a coefficient variation of 3% [2]. Plasma inulin
activity was corrected by refractometry for the contents of
solids in plasma [13]: The mean value of the fraction of water in
arterial plasma (fw) was 0.954 0.001 (SEM, N = 16). Blood
glucose was determined by Reflomat (Boehringer-Mannheim,
Federal Republic of Germany).
Calculations
The plasma volume (VP) was calculated from the injected
amount of albumin tracer (Q)by linear regression:
Log A = log-- — TER tVP (1)
where A is the activity in a minimum of three arterial plasma
samples obtained at the time points (t) during the 1-hr equilib-
rium period preceding the micropuncture experiments and the
regression coefficient (TER) is the transcapillary escape ratio.
Single nephron glomerular filtration rate (SNGFR):
SNGFR = (TF/P)1 VTF (2)
where (TF/P)1 is the tubular fluid to plasma inulin concentration
ratio and VTF the flow rate of tubular fluid.
Single nephron filtration fraction (SNFF) is given by the
following expression [12] which corrects for postglomerular
fluid transport:
SNFF = fw (1 —
AE 'A
(3)
where fw is the fraction of water in arterial plasma and AA and
AE and 'A and 'E indicate afferent and efferent plasma albumin
and inulin activities, respectively. The afferent arteriolar
plasma flow (QJ:
QA = SNGFR SNFF'
and the afferent arteriolar blood flow (GBF):
GBF = QA (1 — HctJ'
(4)
(5)
The hydraulic resistance of the single afferent arteriole (RA):
RA = (AF — F0) GBF' (6)
where XF is the mean arterial pressure and F0 is the mean
glomerular capillary pressure. The hydraulic resistance of the
single efferent arteriole (RE):
RE = (PG — FE) (GBF — SNGFR)1 (7)
where PE is the pressure in the surface efferent arterioles. The
mean transglomerular hydraulic pressure difference (P):
= PG — PB
The effective ultrafiltration pressure (PUF):
PUF(C) = — aC — bC2
(8)
(9)
where a = 0. 1631 1 g', b = 0.00294 l2g2 and C is the plasma
protein concentration in the glomerular capillaries.
The ultrafiltration coefficient of the glomerular membrane
(Kf) is calculated with a mathematical model of the glomerulus
[14] neglecting the small hydraulic pressure decrease along the
glomerular capillaries:
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Table 1. Control period: systemic variables, left kidney function, and hemodynamic determinants of single nephron function in diabetic and
age-matched normal ratsa
Time Left Urinary
after Body kidney Blood Plasma Clearance Urine Na-
induction weight weight glucose CA HctA volume TER GFR albumin flow excretion
days g g mg/di glliter % mi/kg hr1 mi/mm id/mm id/mm tEq/min
Normal rats 87 389 1.35 90 61 46 34 0.14 1.45 1.23 8.3 0.83
N = 7 ±10 ±11 ±0.04 ±4 ±2 ±1 ±1 ±0.01 ±0.05 ±0.18 ±2.2 ±0.31
Diabetic rats 89 302 1.63 310 59 47 38 0.17 1.52 1.92 10,1 1,75
N = 9 ±11 ±13 ±0.08 ±20 ±2 ±1 ±1 ±0.02 ±0.08 ±0.35 ±1.2 ±0.17
P value NS <0.001 <0.01 <0.001 NS NS <0.01 NS NS NS NS <0.05
Abbreviations: CA, systemic plasma protein conc!ntration; HctA, systemic hematocrit; TER, transcapillary escape ratio; A, mean arterial
pressure; PG, mean glomerular capillary pressure; P5, hydraulic pressure in Bowman's space; P, mean transglomerular hydraulic pressure
difference; P, pressure in the surface efferent arterioles; PUF(CE), effective ultrafiltration pressure at the distal extreme of the glomerular
capillary; T and PD, hydraulic pressure in proximal and distal tubules; QA, afferent arteriolar plasma flow; RA and RE, afl'erent and efferent
arteriolar hydraulic resistance to blood flow; RA/RE, ratio between RA and RE; Kf, ultrafiltration coefficient of the glomerular membrane; TF/P
albumin, tubutar fluid to plasma albumin concentration; TF/P inulin, tubular fluid to plasma inulin concentration.
a Values are means ± 5EM; P value was calculated by Student's t test for unpaired data.
CE
i dCI(f = QA CA
CA C2PUF(C)
At filtration disequilibrium, PUF(CE) > 0.5 mm Hg, the efferent
protein concentration (CE);
CE = CA (1 — SNFF'
(10)
Table 2. Regression equations of GFR, mi/mm, and SNGFR, ni/mm,
on the body weight, BW, kg
Diabetic rats (N = 9)GFR = 1.6 — 0.3 BW; r =
—0.13, NS
SNGFR = 82 — 154 BW; r =
—0.59, NS
Normal rats (N = 13)
GFR —0.1 + 3.9 BW; r = 0.89, P <0.001
SNGFR = 6.9 + 74 BW; r = 0.77, P< 0.01
At filtration equilibrium, PUF(CE) E 0.5 mm Hg, CE was
calculated from Eq. (9) assuming PUF(C) to be 0.5 mm Hg.
Statistical analysis was made by Student's t test for paired or
unpaired observations when appropriate. SNGFR and GFR are
functions of body weight so the method of linear regression was
used to calculate the values of weight-matched animals [15].
Results
Control period values (Table 1)
The mean values for SNGFR and whole kidney GFR were
almost the same in the diabetic and the age-matched control rats
despite the significantly lower body weight of the former group
probably caused by catabolism and the large urinary energy loss
as a result of glucosuria. The afferent arteriolar plasma (Q4and
blood flows did not differ significantly. The arterial plasma
protein concentrations (CA) were almost the same in the two rat
groups. Despite the almost identical values of SNGFR, the
glomerular hemodynamics showed striking differences between
the diabetic and control rats: First, the ratio between the
hydraulic resistances of the afferent (RA) and efferent (RE)
arterioles was significantly lower in the diabetic rats despite
similar values for the total arteriolar resistance. This decreased
resistance ratio resulted from a slight decrease in RA below the
normal and a similar increase in RE above normal. Conse-
quently, the hydraulic pressure in the glomerular capillaries
(P0) was substantially higher in the diabetic rats. Furthermore,
the hydraulic pressure in the proximal tubule was slightly lower
in the diabetic animals as a result of a reduced resistance in the
loop of Henle. The mean transglomerular hydraulic pressure
difference (zP) was therefore much higher in these animals.
Second, filtration pressure equilibrium was not reached in the
glomerular capillaries of the diabetic rats. A unique value for
the effective glomerular ultrafiltration coefficient, K1, could
therefore be calculated. In contrast, the control rats were in
filtration pressure equilibrium so it was only possible to calcu-
late a minimum value for K1. The calculated K1 value for the
diabetic rats (2.8 nl min' mm Hg') was substantially lower
than even the minimum K1 value for the control group (5.0 nl
min mm Hg'). Hence, despite the decreased K1 in the
diabetic rats SNGFR is sustained at the same level as in the
control animals by an increase in the transglomerular pressure
difference (AP). The permeation of albumin through the glomer-
ular capillary wall (TF/P albumin) was significantly higher in the
diabetic rats; in contrast, the transcapillary escape rate of
albumin (TER) in the general circulation was similar in the two
animal groups.
These results do not consider the influence of body weight on
GFR and SNGFR. To exclude this effect an unbiased compar-
ison was made using linear regression. Table 2 gives the
relationships between GFR, SNGFR, and body weight. To
calculate these equations for normal rats with a similar range of
body weights as in the diabetic group, it was necessary to
include the results of a recent study with six rats with a body
weight of 260 ± 17 g (Jensen, Christiansen, Steven and Parving
unpublished observations). The values for a diabetic and a
normal rat with a body weight of 302 g (mean value recorded in
the diabetic group) were calculated: GFR, 1.52 ± 0.08 and 1.08
± 0.05 ml/min (P C 0.001); SNGFR, 35.5 ± 2.8 and 29.2 ± 1.7
nllmin (P C 0.05), respectively. These results demonstrate that
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Table 1. (Continued)
AP PG PB P PE PUF(CE) PT PD SNGFR QA RA RE K1
nI mm TF/P TF/P
mm Hg ni/mm Gdyn sec cm5 RA/RE mm Hg' albumin inulin
107 47.1 13.7 33.5 16.9 —2.3 12.6 8.0 32.8 120 26 16 1.7 5.0 0,010 1.8
±2 ±0.8 ±0.2 ±0.6 ±1.1 ±2.8 ±0.5 ±0.6 ±2.8 ±22 ±5 ±3 ±0.2 ±0.6 ±0.002 ±0.1
108 53.6 11.6 42.0 15.0 7.0 11.1 8.7 35.5 116 21 17 1.2 2.8 0.028 2.1
±3 ±2.0 ±0.3 ±1.9 ±0.7 ±2.9 ±0.5 ±0.6 ±3.3 ±8 ±2 ±1 ±0.1 ±0.6 ±0,007 ±0.2
NS <0.05 <0.001 <0.01 NS <0.05 <0.05 NS NS NS NS NS <0.05 <0.05 <0.05 NS
Table 3. Change in renal function during infusion of 3.2 mI/h of 0.9% NaC1 in normal rats
Infusion rate PG
of 0.9% NaCI CA GFR SNGFR
mi/hr g/liter mi/mm ni/mm mm Hg
Control period (N = 4) 1.2 58 ± 2 0.96 ± 0.17 26 ± 1 48.4 ± 0.5 13.0 ± 0.5
Change during experimental period +2.0 —7 ± 1 —0.04 ± 0.12 —0.7 ± 0.9 +0.6 ± 0.5 +0.1 ± 0.3
P value (paired t test) — <0.05 NS NS NS NS
For abbreviations, see Table 1.
diabetic rats have a higher glomerular filtration rate than
weight-matched normal animals.
Table 3 shows the results of the separate experiments which
were made to examine whether the differences in renal function
between the two groups were caused by the higher rate of saline
infusion in the diabetic rats: The higher infusion rate in normal
rats resulted in a significant decrease in the arterial plasma
protein concentration but was associated neither with signifi-
cant changes in SNGFR and GFR nor in the hydraulic pressures
in the glomerular capillaries and Bowman's space.
Indomethacin infusion period (Table 4, Fig. 1)
Indomethacin produced striking changes in the glomerular
microcirculation of the diabetic rats but failed to cause any
changes in the control animals. The following changes were
recorded in the diabetic rats: The hydraulic resistance of the
afferent arteriole (RAJ increased substantially, the efferent arte-
riolar resistance (RE) increased moderately. Consequently, the
hydraulic pressure in the glomerular capillaries (PG) decreased
to a value almost identical to that recorded in the control
animals. The hydraulic pressure in Bowman's space (PB) was
slightly but significantly decreased, Consequently, the mean
transglomerular hydraulic pressure difference (P) was signifi-
cantly reduced. Accordingly, SNGFR decreased significantly.
Filtration pressure equilibrium was now reached in the glomer-
ular capillaries so it was only possible to calculate a minimum
value of the ultrafiltration coefficient (Kf) which was almost the
same as the control period values. In accordance with these
results, indomethacin infusion was found to be associated with
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a significant decrease in whole kidney GFR but failed to cause
any change in the control rats.
The effect of indomethacin on nephron function in the dia-
betic rats was not a result of volume depletion because both the
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Fig. 1. The values of the transgiomerular hydraulic pressure difference(P) in the control period on the abscissa are plotted against the values
in the experimental period on the ordinate. The line of identity is
shown. Symbols are: open squares, normal rats given indomethacin;
closed circles, time-control diabetic rats given vehicle: open circles,
diabetic rats given indomethacin.
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Normal rats
Indomethacin
Paired t test
P value
4 +7.2
NS
—5
NS
—2
NS
+3
NS
+0.7
NS
+0.6
NS
+0.1
NS
—3.0
MS
+7.1
MS
Diabetic rats
Indomethacin
Paired (test
P value
6 —23.4
<0.05
—3
NS
—2
MS
—2
NS
—9,3
<0.005
—1.4
<0.05
—7.9
<0.01
—1.7
MS
—5.4
<0.05
Diabetic rats
Time control
Paired (test
P value
3 —24.8
NS
—5
MS
0
MS
0
NS
+0.8
<0.01
—0.1
NS
+1.0
NS
+0.5
MS
+5.4
NS
For abbreviations , see Table 1.
value for urinary sodium excretion and plasma volume were
higher in diabetic than in normal rats (Table I).
Table 4 gives the results of the time control studies showing
only slight changes in glomerular hemodynamics in the diabetic
rats. The effect of indomethacin infusion in diabetic rats was
therefore not a result of time-dependent alterations in renal
function occurring during micropuncture.
Discussion
Experimental results suggest that diabetic glomerulopathy is
associated with striking changes in glomerular hemodynamics
which are compensated by an increased prostaglandin produc-
tion. These effects will therefore only be fully apparent when
the endogeneous prostaglandin synthesis is inhibited resulting
in the following hemodynamic differences between diabetic rats
and age-matched control animals: a substantial increase in the
afferent hydraulic resistance and a moderate rise in the efferent
resistance associated with a significant decrease in K1. These
changes cause significant decreases in both SNGFR and the
afferent arteriolar blood flow below the normal level. The rise in
the afferent resistance could be caused by structural or func-
tional changes in the intrarenal arteries and arterioles while the
decrease in Kf could be effected by thickening of the glomerular
basement membrane [31 or alteration in the composition of the
membrane, and mesangial matrix enlargement [161.
The hemodynamic changes induced by the diabetic glomer-
ulopathy are compensated in the following manner: The resis-
tances of the afferent and efferent arterioles are reduced result-
ing in a normal total nephron resistance. The decrease in the gb-
merular ultrafiltration coefficient is compensated by an increase
in glomerular capillary pressure resulting from a decrease in the
ratio between the afferent and efferent resistances. As a result
of these changes, SNGFR and afferent arteriolar blood flow will
rise to normal. Hence, despite the hemodynamic difference
between the diabetic and the control rats the only differences
that can be recorded when prostaglandin synthesis remains
uninhibited are a decreased glomerular ultrafiltration coefficient
and an increased pressure in the glomerular capillaries.
The present results agree with previous studies showing that
inhibition of prostaglandin synthesis has no effect on glomerular
hemodynamics in normal rats [6, 17]. Our results agree with
studies showing that prostaglandin secretion maintains GFR in
patients with nephrosis [7], in rats with chronic partial ureteral
obstruction [6], and in rabbits made uremic by reduction of the
renal mass [8]. Indomethacin has no effect on the increased
GFR in patients with insulin-dependent diabetes of short dura-
tion [18], but the effect on patients with long-term insulin-
dependent diabetes remains unknown.
Indomethacin is not a specific inhibitor of cyclooxygenase
activity [191 as it may impair other enzyme systems; neverthe-
less, we only used this agent because there are no qualitative
differences between the cycbooxygenase inhibitors [11], and
higher doses of indomethacin are required to impair the other
enzyme systems [19].
Glomerular function is determined by a complex interaction
of the renin-angiotensin system, vasopressin, prostaglandin and
kallikrein-kinin systems. In severely diabetic rats the plasma
renin activity is decreased [20, 21] and the vasopressin concen-
tration is increased [22]; the prostacyclin concentration remains
unknown since an increased concentration was found in one
study [23] and a decreased in another [21]. Prostacyclin pro-
duction is reduced in the aorta and the renal cortex [24], but it
is increased in isolated glomeruli of diabetic rats [25, 26].
Our results agree with those of Hostetter, Troy, and Brenner
[1] showing a substantially higher filtration rate in moderately
hyperglycemic diabetic rats than in weight-matched control
rats. In contrast to their earlier finding K1 was significantly
lower in the diabetic rats than in the control animals in the
present study. Two explanations may account for this discrep-
ancy: First, the arterial plasma protein concentration which is
known to exert a strong influence on K1 [271 was substantially
higher in the diabetic rats than in the control animals in the
earlier study [11. Second, in contrast to the previous study [1]
the two animal groups were age- and not weight-matched in the
present experiments because the morphological changes in the
kidney are known to be age-dependent in both normal and
diabetic rats [3].
Blood
glucose
N mg/dl
Table 4. Change in hemodynamic determinants of whole kidney and single nephron during infusion of indomethacin in diabetic and
age-matched control rats
CA HctA
glliter vol%
AP P0 PB SF Pa PUF(C5)
mm Hg
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Table 4. (Continued)
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GFR
mi/mm
SNGFR QA RA RE
RA/RE
Kf
ni min
mm Hg'
Urinary
Na-excretion
pEqiminni/mm Gdyn sec cm5
—0.18 —2.3 —8.2 —4.6 —2.6 —0.13 —1,5 +0.47
NS NS NS NS NS NS NS NS
—0.59 —11.1 —36.1 +16.8 +5.0 +0.40 —0.3 +0.34
<0.05 <0.005 <0.002 <0.001 <0.05 <0.01 NS NS
—0.15 —5.0 —5.6 +3.9 +4.4 —0.04 —1.8 —0.28
NS NS NS NS NS NS NS NS
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